Focus:
-
![]()
Data shows majority of Australian sites are open for clinical trial activity
Novotech, the Asia-Pacific CRO, has published data detailing the current status of clinical trials in the Asia-Pacific region during the global COVID-19 crisis. According to their data, the top 10...
-
![antimalarial drugs; covid-19]()
Managing the Covid-19 outbreak: Lessons learnt from South Korea
Due to its geographic proximity with China, South Korea was one of the first locations hit with the Covid-19 viral infections.
-
![Asia-pacific clinical trials]()
Clinical trials data report for Asia-Pacific: Frost & Sullivan collaborates with Novotech
Business consulting firm Frost & Sullivan and Asia-Pacific CRO specialist Novotech published a report summarising the main trends and developments in Asia’s clinical outsourcing landscape. The report highlights the main...
-
![global CRO]()
Novotech case study: Global reach through CRO partnership for a phase 2 oncology trial
The alliance of regional specialists can provide the best of all worlds: global coverage, regional specialisation and mid-sized CRO flexibility.
-
![]()
Case studies in accelerating clinical trials in oncology
Clinical development in oncology and immunotherapies has accelerated dramatically over the past few years.
